MENU
KTTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pasithea Therapeutics (KTTA) Ownership - Who owns Pasithea Therapeutics?
Pasithea Therapeutics Corp is a biotechnology company... Show more
Profile
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.85M
P/E Ratio
N/A
Total Cash
5.34M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KTTA
Capitalization
5.85M
P/E Ratio
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash
5.34M
Total Cash/Share
0.72
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
13M
P/B Ratio
0.45
Cash Flow
N/A
Earnings
-10.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
270
Current Ratio
3.84
Current Revenue Per Employee
16047.47
Dividends Per Share - Security
N/A
EBITDA
-13.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.54
Revenue To Assets
-73.42
Shares Held By Institutions
156K
Shares Outstanding - Current
7.44M
Total Liabilities
1.68M
Total Volume MTD
N/A
Value
1
Gain YTD
-75.048
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1111 Lincoln Road
Phone
+1 702 514-4174
Employees
8
Web
https://www.pasithea.com